← Eichor
Condition: Hematopoetic Stem Cell Transplant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hematopoetic Stem Cell Transplant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Preventing of GVHD with Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Ruxolitinib At Children and Yo
Phase 2/Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT06756152Aromatherapy Inhaler Use for HSCT Distress
NA · 1 location(s) · Stanford University · NCT05302583Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Phase 1/Phase 2 · 4 location(s) · Arkansas Children's Hospital Research Institute · NCT07252050Exercise as an Immune Adjuvant for Allogeneic Cell Therapies
EARLY_Phase 1 · 1 location(s) · University of Arizona · NCT06643221G-CSF Combined With IL-11 on Hematopoietic Reconstitution After Autologous Hematopoietic Stem Cell Transplantation
Phase 2 · 3 location(s) · Fudan University · NCT07362810Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
NA · 1 location(s) · University of Pittsburgh · NCT07107165
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.